After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ZVRA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Zevra Therapeutics Inc is $381.52M. A total of 0.92 million shares were traded on the day, compared to an average of 437.24K shares.
In the most recent transaction, Watton Corey Michael bought 300 shares of ZVRA for 7.84 per share on Mar 28 ’25. After the transaction, the Director now owns 1,800 company shares. In a previous transaction on Mar 19 ’25, Bode John B bought 10,000 shares at 7.96 per share. ZVRA shares that Director owns now total 40,000.
Among the insiders who sold shares, Sangiovanni Timothy J. disposed of 3,000 shares on Feb 13 ’25 at a per-share price of $7.86. This resulted in the SVP, Finance & Corp Controller holding 16,341 shares of ZVRA after the transaction. In another insider transaction, Schafer Joshua sold 10,500 shares at $7.86 per share on Feb 13 ’25. Company shares held by the CCO & EVP, Bus. Development now total 29,486.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ZVRA has a high of $9.76 and a low of $4.20.
As of this writing, ZVRA has an earnings estimate of -$0.19 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.15 per share and a lower estimate of -$0.24.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ZVRA’s latest balance sheet shows that the firm has $112.35M in Cash & Short Term Investments as of fiscal 2021. There were $1.61M in debt and $4.23M in liabilities at the time. Its Book Value Per Share was $0.74, while its Total Shareholder’s Equity was $127.12M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZVRA is Buy with a score of 5.00.
